These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6128634)

  • 1. Tumour localisation with monoclonal antibody radioactivity labelled with metal chelate rather than iodine.
    Rainsbury R; Westwood J
    Lancet; 1982 Dec; 2(8311):1347-8. PubMed ID: 6128634
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours.
    Epenetos AA; Britton KE; Mather S; Shepherd J; Granowska M; Taylor-Papadimitriou J; Nimmon CC; Durbin H; Hawkins LR; Malpas JS; Bodmer WF
    Lancet; 1982 Nov; 2(8306):999-1005. PubMed ID: 6127540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved tumour localisation using indium-111 labelled antibodies.
    Fairweather DS; Bradwell AR; Dykes PW; Vaughan AT; Watson-James SF; Chandler S
    Br Med J (Clin Res Ed); 1983 Jul; 287(6386):167-70. PubMed ID: 6409238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newer approaches to the radiolabeling of monoclonal antibodies by use of metal chelates.
    Gansow OA
    Int J Rad Appl Instrum B; 1991; 18(4):369-81. PubMed ID: 1864725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior localisation and imaging of radiolabelled monoclonal antibody E48 F(ab')2 fragment in xenografts of human squamous cell carcinoma of the head and neck and of the vulva as compared to monoclonal antibody E48 IgG.
    Gerretsen M; Quak JJ; Suh JS; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
    Br J Cancer; 1991 Jan; 63(1):37-44. PubMed ID: 1989663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Location of metastatic breast carcinoma by a monoclonal antibody chelate labelled with indium-111.
    Rainsbury RM; Ott RJ; Westwood JH; Kalirai TS; Coombes RC; McCready VR; Neville AM; Gazet JC
    Lancet; 1983 Oct; 2(8356):934-8. PubMed ID: 6138503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in tumour and normal tissue concentrations of iodine- and indium-labelled monoclonal antibody. I. The effect on image contrast in clinical studies.
    Perkins AC; Pimm MV
    Eur J Nucl Med; 1985; 11(8):295-9. PubMed ID: 4076237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for radiolabelling of monoclonal antibodies.
    Tolmachev V; Orlova A; Andersson K
    Methods Mol Biol; 2014; 1060():309-30. PubMed ID: 24037848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localisation of human osteosarcoma by antitumour monoclonal antibody.
    Farrands PA; Perkins A; Sully L; Hopkins JS; Pimm MV; Baldwin RW; Hardcastle JD
    J Bone Joint Surg Br; 1983 Nov; 65(5):638-40. PubMed ID: 6358231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential imaging of indium-111-labeled monoclonal antibody in human mammary tumors hosted in nude mice.
    Khaw BA; Strauss HW; Cahill SL; Soule HR; Edgington T; Cooney J
    J Nucl Med; 1984 May; 25(5):592-603. PubMed ID: 6726438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The detection of ovarian cancer using 123J monoclonal antibody.
    Granowska M; Britton KE; Shepherd J
    Radiobiol Radiother (Berl); 1984; 25(1):153-60. PubMed ID: 6729079
    [No Abstract]   [Full Text] [Related]  

  • 12. Bifunctional chelating agents for radiometal-labeled monoclonal antibodies.
    Subramanian R; Meares CF
    Cancer Treat Res; 1990; 51():183-99. PubMed ID: 1977444
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of humoral immune responses against a macrocyclic chelating agent (DOTA) in cancer patients receiving radioimmunoconjugates for imaging and therapy.
    Kosmas C; Snook D; Gooden CS; Courtenay-Luck NS; McCall MJ; Meares CF; Epenetos AA
    Cancer Res; 1992 Feb; 52(4):904-11. PubMed ID: 1737353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioimmunodetection of human colorectal cancers by an anti-tumour monoclonal antibody.
    Farrands PA; Perkins AC; Pimm MV; Embleton MJ; Hardy JD; Baldwin RW; Hardcastle JD
    Lancet; 1982 Aug; 2(8295):397-400. PubMed ID: 6124802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chelates and antibodies: current methods and new directions.
    Gansow OA; Brechbiel MW; Mirzadeh S; Colcher D; Roselli M
    Cancer Treat Res; 1990; 51():153-71. PubMed ID: 1977442
    [No Abstract]   [Full Text] [Related]  

  • 16. Labeling of monoclonal antibodies with radionuclides.
    Bhargava KK; Acharya SA
    Semin Nucl Med; 1989 Jul; 19(3):187-201. PubMed ID: 2503873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First experiments on radioimmunodetection with b-12-monoclonal antibody fragments against breast cancer antigen.
    Fridrich R; Andres R; Stähli C; Zenklusen HR
    Nuklearmedizin; 1986 Dec; 25(6):225-6. PubMed ID: 3808963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiolabelled monoclonal antibodies in tumour diagnosis and therapy.
    Kosmas C; Kalofonos HP; Epenetos AA
    Dev Biol Stand; 1990; 71():93-102. PubMed ID: 2401391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Labeling of anti-tumor antibodies and antibody fragments with Tc-99m.
    Hansen HJ; Jones AL; Grebenau R; Kunz A; Goldenberg DM
    Cancer Treat Res; 1990; 51():233-44. PubMed ID: 1977447
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preparation of 125I-labelled monoclonal antibodies of the insulin receptor].
    Sesti G; Marini MA; Montemurro A; Di Daniele N; Bertoli A; Cordera R; Andraghetti G; De Pirro R; Lauro R; Monaco F
    C R Seances Soc Biol Fil; 1988; 182(2):167-76. PubMed ID: 2973824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.